Does diabetes mellitus target motor neurons?
暂无分享,去创建一个
Douglas W. Zochodne | D. Zochodne | Cory Toth | J. Kennedy | Noor Ramji | James Kennedy | C. Toth | N. Ramji
[1] D. Zochodne,et al. The regenerative deficit of peripheral nerves in experimental diabetes: its extent, timing and possible mechanisms. , 2000, Brain : a journal of neurology.
[2] A. Schmidt,et al. Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes , 2002, Ageing Research Reviews.
[3] S. Yagihashi,et al. Pathogenetic mechanisms of diabetic neuropathy: lessons from animal models. , 1997, Journal of the peripheral nervous system : JPNS.
[4] D. Wolgemuth,et al. Crosstalk between p38, Hsp25 and Akt in spinal motor neurons after sciatic nerve injury. , 2001, Brain research. Molecular brain research.
[5] M. Fahim,et al. Muscle contractility decrement and correlated morphology during the pathogenesis of streptozotocin‐diabetic mice , 1998, The Anatomical record.
[6] S. Kuwabara,et al. The acute effects of glycemic control on nerve conduction in human diabetics , 2005, Clinical Neurophysiology.
[7] H. Kiyama,et al. Akt/Protein Kinase B Prevents Injury-Induced Motoneuron Death and Accelerates Axonal Regeneration , 2000, The Journal of Neuroscience.
[8] G. Grimby,et al. Muscle adaptive changes in post-polio subjects. , 1989, Scandinavian journal of rehabilitation medicine.
[9] Sicco A Bus,et al. Intrinsic muscle atrophy and toe deformity in the diabetic neuropathic foot: a magnetic resonance imaging study. , 2002, Diabetes care.
[10] N. Cashman,et al. Electrophysiology and electrodiagnosis of the post-polio motor unit. , 1991, Orthopedics.
[11] H. Vlassara,et al. Diabetes and advanced glycation endproducts , 2002, Journal of internal medicine.
[12] H. Andersen,et al. Motor function in diabetic neuropathy , 1999, Acta neurologica Scandinavica.
[13] B. Arvidson. Distribution of protein tracers in peripheral ganglia : a light and electron microscopic study in rodents after various modes of tracer administration , 1979 .
[14] D. Zochodne,et al. Experimental diabetic neuropathy with spontaneous recovery: is there irreparable damage? , 2005, Diabetes.
[15] Jeremy M. Shefner,et al. Motor unit number estimation in human neurological diseases and animal models , 2001, Clinical Neurophysiology.
[16] J. Ulbrecht,et al. Glucose-induced Alterations in Nerve Metabolism: Current Perspective on the Pathogenesis of Diabetic Neuropathy and Future Directions for Research and Therapy , 1985, Diabetes Care.
[17] Henning Andersen,et al. Atrophy of foot muscles: a measure of diabetic neuropathy. , 2004, Diabetes care.
[18] S. Snyder,et al. Poly(ADP-ribose) Polymerase-1 in the Nervous System , 2000, Neurobiology of Disease.
[19] Johannes Buchner,et al. Regulation of Hsp27 Oligomerization, Chaperone Function, and Protective Activity against Oxidative Stress/Tumor Necrosis Factor α by Phosphorylation* , 1999, The Journal of Biological Chemistry.
[20] C. Helke,et al. Abnormal PI3 kinase/Akt signal pathway in vagal afferent neurons and vagus nerve of streptozotocin-diabetic rats. , 2003, Brain research. Molecular brain research.
[21] A. Schmidt,et al. Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. , 2002, Advanced drug delivery reviews.
[22] M. Gaestel,et al. Small heat shock proteins are molecular chaperones. , 1993, The Journal of biological chemistry.
[23] J. Chen,et al. The Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin , 1995, The Journal of Biological Chemistry.
[24] A. Goldberg,et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] M. Messi,et al. Target-Derived Trophic Effect on Skeletal Muscle Innervation in Senescent Mice , 2003, The Journal of Neuroscience.
[26] P. Low,et al. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. , 1984, Brain : a journal of neurology.
[27] D. Zochodne,et al. Sensory neurons with activated caspase-3 survive long-term experimental diabetes. , 2003, Diabetes.
[28] M. Matsumoto,et al. Rage: A Novel Cellular Receptor for Advanced Glycation End Products , 1996, Diabetes.
[29] Hideyuki Sasaki,et al. Neuropathology and blood flow of nerve, spinal roots and dorsal root ganglia in longstanding diabetic rats , 1997, Acta Neuropathologica.
[30] Circulating IGF‐I and its protective role in the pathogenesis of diabetic angiopathy , 2000, Clinical endocrinology.
[31] H. Vlassara. The AGE‐receptor in the pathogenesis of diabetic complications , 2001, Diabetes/metabolism research and reviews.
[32] M. Pfaffl,et al. A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.
[33] D. Zochodne,et al. The Influence of Indomethacin and Guanethidine on Experimental Streptozotocin Diabetic Neuropathy , 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.
[34] Guido Kroemer,et al. Hsp27 negatively regulates cell death by interacting with cytochrome c , 2000, Nature Cell Biology.
[35] H. S. Neto,et al. Acetylcholine receptors and nerve terminal distribution at the neuromuscular junction of non‐obese diabetic mice , 2002, The Anatomical record.
[36] M. Hasan,et al. Early morphological remodeling of neuromuscular junction in a murine model of diabetes. , 2000, Journal of applied physiology.
[37] D. Cimino,et al. Heat shock protein 27 stimulates recovery of RNA and protein synthesis following a heat shock , 1997, Journal of cellular biochemistry.
[38] Fei Li,et al. Role of poly(ADP-ribose) polymerase activation in diabetic neuropathy. , 2004, Diabetes.
[39] E. Feldman,et al. IGF-I prevents glutamate-induced motor neuron programmed cell death , 2004, Neurobiology of Disease.
[40] J. Lord,et al. Serine/threonine protein kinases and apoptosis. , 2000, Experimental cell research.
[41] Tessa Gordon,et al. Experimental strategies to promote functional recovery after peripheral nerve injuries , 2003, Journal of the peripheral nervous system : JPNS.
[42] S. Hansen,et al. Axonal dysfunction in the neuropathy of diabetes mellitus: a quantitative electrophysiological study. , 1977, Journal of neurology, neurosurgery, and psychiatry.
[43] A. Boulton,et al. Diabetic neuropathies and pain. , 1986, Clinics in endocrinology and metabolism.
[44] A. Sima,et al. New insights into the metabolic and molecular basis for diabetic neuropathy , 2003, Cellular and Molecular Life Sciences CMLS.
[45] R. Coggeshall,et al. Methods for determining numbers of cells and synapses: A case for more uniform standards of review , 1996, The Journal of comparative neurology.
[46] T. Gordon,et al. Mechanisms controlling axonal sprouting at the neuromuscular junction , 2003, Journal of neurocytology.
[47] P. Low,et al. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. , 2003, Diabetes.
[48] C. Cheng,et al. Does diabetes target ganglion neurones? Progressive sensory neurone involvement in long-term experimental diabetes. , 2001, Brain : a journal of neurology.
[49] C. Cheng,et al. Diabetes Mellitus and the Sensory Neuron , 2004, Journal of neuropathology and experimental neurology.
[50] M. Cudkowicz,et al. Comparison of incremental with multipoint MUNE methods in transgenic ALS mice , 2002, Muscle & nerve.